Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Becaplermin Gel for Martorell's Hypertensive Leg Ulcers
NCT00970697Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2004
- Primary completion
- May 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of becaplermin in Martorell hypertensive ischemic leg ulcer (HILU), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2004; status: completed.
02
Drugs
becaplermin
03
Conditions
Martorell hypertensive ischemic leg ulcer (HILU)
Beyond the preview
Go deeper on NCT00970697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970697.